• Shannon M Dunlay, Soon J Park, Lyle D Joyce, Richard C Daly, John M Stulak, Sheila M McNallan, Véronique L Roger, and Sudhir S Kushwaha.
• Division of Cardiovascular Diseases, Department of Internal Medicine, Rochester, Minnesota; Department of Health Sciences Research, Rochester, Minnesota. Electronic address: dunlay.shannon@mayo.edu.
• J. Heart Lung Transplant. 2014 Apr 1; 33 (4): 359-65.

BackgroundFrailty is recognized as a major prognostic indicator in heart failure. There has been interest in understanding whether pre-operative frailty is associated with worse outcomes after implantation of a left ventricular assist device (LVAD) as destination therapy.MethodsPatients undergoing LVAD implantation as destination therapy at the Mayo Clinic, Rochester, Minnesota, from February 2007 to June 2012, were included in this study. Frailty was assessed using the deficit index (31 impairments, disabilities and comorbidities) and defined as the proportion of deficits present. We divided patients based on tertiles of the deficit index (>0.32 = frail, 0.23 to 0.32 = intermediate frail, <0.23 = not frail). Cox proportional hazard regression models were used to examine the association between frailty and death. Patients were censored at death or last follow-up through October 2013.ResultsAmong 99 patients (mean age 65 years, 18% female, 55% with ischemic heart failure), the deficit index ranged from 0.10 to 0.65 (mean 0.29). After a mean follow-up of 1.9 ± 1.6 years, 79% of the patients had been rehospitalized (range 0 to 17 hospitalizations, median 1 per person) and 45% had died. Compared with those who were not frail, patients who were intermediate frail (adjusted HR 1.70, 95% CI 0.71 to 4.31) and frail (HR 3.08, 95% CI 1.40 to 7.48) were at increased risk for death (p for trend = 0.004). The mean (SD) number of days alive out of hospital the first year after LVAD was 293 (107) for not frail, 266 (134) for intermediate frail and 250 (132) for frail patients.ConclusionsFrailty before destination LVAD implantation is associated with increased risk of death and may represent a significant patient selection consideration.Copyright © 2014 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

33 keywords...

hide…